Skip to content
MedsAcross

Medicine

Scopolamine Trandermal System 1 mg transdermal patch

Scopolamine · Transdermal · Bryant Ranch Prepack
Available on requestPrescription onlyUS FDA

Scopolamine Trandermal System 1 mg transdermal patch is a prescription medicine containing Scopolamine for transdermal use, marketed by Bryant Ranch Prepack, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F). Store pouch(es) in an upright position.

Key facts

Active ingredient (INN)
Scopolamine
Brand
Scopolamine Trandermal System
Strength
1 mg
Dosage form
Transdermal patch
Route
Transdermal
Packs
24 pouches, 10 pouches, 4 pouches and 3 more
Marketing authorisation holder
Bryant Ranch Prepack
Manufacturer
Bryant Ranch Prepack
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F). Store pouch(es) in an upright position.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A04AD01 Scopolamine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
13 June 2017
Identifiers
RxCUI 226552DailyMed set ID 69401d6f-3d18-48b0-b28c-a578c9834f32, 81c57d46-1617-4295-8a60-acb7e365551c, 1099a330-fcb8-4acd-9ef8-525024c6b9d6 +1NDC 72162-1419, 63629-8452, 63629-8451 +1Application ANDA078830

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
24 pouch in 1 carton / 1 patch, extended release in 1 pouch63629-8450-1Bryant Ranch Prepack4 April 2024
10 pouch in 1 carton / 1 patch, extended release in 1 pouch63629-8451-1Bryant Ranch Prepack29 April 2021
4 pouch in 1 carton / 1 patch, extended release in 1 pouch63629-8452-1Bryant Ranch Prepack29 April 2021
24 pouch in 1 carton / 1 patch, extended release in 1 pouch72162-1419-2Bryant Ranch Prepack30 August 2023
4 pouch in 1 carton / 1 patch, extended release in 1 pouch72162-1419-4Bryant Ranch Prepack30 August 2023
10 pouch in 1 carton / 1 patch, extended release in 1 pouch72162-1419-7Bryant Ranch Prepack30 August 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 31 December 1979Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Scopolamine 1 mg transdermal patch.

Compare 1

Other strengths and forms of Scopolamine

Clinical summary

Scopolamine is an anticholinergic indicated in adults for the prevention of nausea and vomiting associated with motion sickness, among other approved uses. It is available as transdermal patches and transdermal systems. MedsAcross supplies Scopolamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Scopolamine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Scopolamine Trandermal System 1 mg transdermal patch for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.